5 completed, 4 recruiting. 9 Phase 1, 8 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Completed 5, Recruiting 4 |
| Phase 2 | 8 | Completed 4, Recruiting 4 |
Follow Supportive care: new trials by email Literature Review of Supportive care trials Research Report on Supportive care
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dual-Target CAR-NK Cells Targeting MSLN, EGFR, or HER2 in Advanced NSCLC Dual-target CAR-NK cells, Lymphodepleting chemotherapy, Supportive care - Non-Small Cell Lung Cancer, Advanced/Metastatic | Phase 1 / Phase 2 | Recruiting | Beijing Biotech | 60 | 2026-03-02 | 2026-06-11 |
| Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC Dual-target CAR-NK cells, Lymphodepleting chemotherapy, Supportive Care - Non-Small Cell Lung Cancer, Advanced/Metastatic NSCLC | Phase 1 / Phase 2 | Recruiting | Beijing Biotech | 48 | 2026-02-02 | 2026-03-12 |
| Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC Dual-target CAR-NK cells, Lymphodepleting, Supportive care - Breast Cancer (Advanced/Metastatic), HER2-positive Breast Cancer | Phase 1 / Phase 2 | Recruiting | Beijing Biotech | 60 | 2026-02-02 | 2026-04-06 |
| Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC) Dual-target CAR-NK cells (EB-DT-CAR-NK), Lymphodepleting chemotherapy, Supportive care - Breast Cancer (Locally Advanced or Metastatic), HER2-positive Breast Cancer | Phase 1 / Phase 2 | Recruiting | Beijing Biotech | 60 | 2026-02-02 | 2026-03-20 |
| Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease) Mesenchymal Stromal Cells, Supportive Care - Sars-CoV2, Acute Respiratory Distress Syndrome | Phase 1 / Phase 2 | Completed | Baylor College of Medicine | 28 | 2021-02-12 | 2026-10-21 |
| Interactive Care Plan for the Monitoring of Symptoms and Recovery in Patients With Stage 0-III Breast Cancer Quality-of-Life Assessment, Questionnaire Administration, Supportive Care - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Phase 1 | Completed | Mayo Clinic | 100 | 2020-08-20 | 2023-09-15 |
| Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung Cancer vitamin C, Modulated Electro-Hyperthermia (mEHT), Supportive care - Carcinoma, Non-Small-Cell Lung, Stage IIIA Non-small Cell Lung Cancer | Phase 1 / Phase 2 | Completed | Clifford Hospital, Guangzhou, China | 97 | 2015-12-01 | 2018-11-30 |
| A Controlled Clinical Trial on The Use of a Specific Antivenom Against Envenoming by Bungarus Multicinctus Bungarus multicinctus-candidus Antivenom, Supportive Care - Snake Bite | Phase 1 / Phase 2 | Completed | Hanoi Medical University | 81 | 2004-03-01 | 2008-12-18 |
| Sirolimus in Treating Patients With Glioblastoma Multiforme Rapamycin, Surgery, Supportive Care - Brain and Central Nervous System Tumors | Phase 1 / Phase 2 | Completed | Jonsson Comprehensive Cancer Center | 13 | 2002-07-01 | 2020-08-03 |
Carcinoma, Non-Small-Cell Lung (3) · Neoplasm Metastasis (3) · Breast Neoplasms (2) · Triple Negative Breast Neoplasms (2) · Brain Neoplasms (1) · Breast Carcinoma In Situ (1) · COVID-19 (1) · Central Nervous System Neoplasms (1) · Glioblastoma (1) · Gliosarcoma (1) · Respiratory Distress Syndrome (1) · Respiratory Insufficiency (1) · Snake Bites (1)
Beijing Biotech (4) · Baylor College of Medicine (1) · Clifford Hospital, Guangzhou, China (1) · Hanoi Medical University (1) · Jonsson Comprehensive Cancer Center (1) · Mayo Clinic (1)
China (5) · United States (3) · Vietnam (1)
Daniela L Stan, M.D. (1) · Helen Heslop, MD (1) · Junwen Ou, PhD (1) · LaQuisa Hill, MD (1) · Timothy F. Cloughesy, MD (1)
PMID 11174237, PMID 11837876, PMID 18215105, PMID 20358414, PMID 8544231, PMID 9042094, PMID 9509180, PMID 9792162
P30CA015083 (1)